Wells Fargo upgrades International Paper stock rating on improved operations

Wells Fargo upgraded International Paper to Overweight and lifted its target to $39 from $38, citing step-change operational improvements and a clearer path to year-over-year EBITDA growth. The firm raised 2026/2027 EBITDA estimates to $3.12 billion and $4.05 billion, and highlighted a 5.82% dividend yield backed by 56 consecutive years of payouts. Q1 2026 EPS came in at $0.15 versus $0.14 expected, though revenue missed at $5.97 billion versus $6.01 billion consensus.

Analysis

The real signal here is not the modest target increase, but the narrowing gap between what the market is paying and what management can plausibly deliver if pricing discipline holds. IP is turning from a macro-call into a self-help story: when operating fixes, mill rationalization, and portfolio actions drive the majority of EBITDA uplift, the stock can rerate even if industrial demand stays mediocre. That makes the name more resilient than a typical packaging cyclical, and also means the next leg higher is likely to be driven by estimate revisions rather than multiple expansion alone.

The biggest second-order effect is on competitors with weaker cost structures: if North American containerboard capacity keeps coming out, the marginal producer loses pricing power faster than investors expect. That favors the better-capitalized incumbents and squeezes smaller regional players that cannot absorb downtime or pass through cost inflation. The Europe/Middle East/Africa improvement angle matters too, but the market is likely underestimating how much of the upside is simply removing idiosyncratic drags, which is usually worth more in a slow-growth tape than a heroic end-demand thesis.

The key risk is timing. The positive thesis is durable over 6-18 months, but the stock can stall if investors decide the 2027 EBITDA path is too far out or too dependent on clean execution. Any disappointment on pricing realization, conversion costs, or labor/energy input inflation could compress the multiple back toward a low-7x or sub-7x EBITDA regime quickly, especially if broader industrials weaken.

Consensus is probably underappreciating the dividend as a floor for capital allocation rather than just yield support. In a market where investors are paying up for cash-return visibility, a high-yield cyclically improving name can attract both value and income buyers once the market believes the inflection is real. The contrarian view is that the current setup may still be too cheap if the company is merely decent, but too expensive if the operating gains prove one-off rather than repeatable.

Key Decisions for Investors

• Go long IP on a 3-6 month horizon; add on weakness toward the low-$30s with a base-case target near the current analyst framework and upside optionality if EBITDA revisions continue.
• Use a call spread in IP for a 6-9 month view to express rerating potential without taking full equity beta; attractive if you expect the market to believe the 2026-2027 bridge before it fully prints.
• Pair long IP / short a higher-cost packaging or paper peer that lacks visible self-help and capital return support; this isolates execution alpha from the sector beta.
• Watch for a failed follow-through if IP cannot hold post-upgrade gains over the next 2-4 weeks; that would signal the market still views the 2027 story as aspirational and cap upside near-term.
• If you want income plus upside, accumulate only if the dividend remains covered through the next print; the yield improves downside protection, but any cash flow miss would quickly reprice the stock.